Daily Maverick 168 weekly newspaper.
The price of oil had jumped from $4 a barrel to $12 and his mind was occupied with the need for alternative energy sources and improved batteries for energy storage. He was later joined in this quest by PhD student Michael Thackeray. Their studies into battery materials heralded the start of a glorious 20-year period when the CSIR, supported by Anglo American, De Beers and the South African Inventions Development Corporation, as it was then known, made major contributions to advancing international battery science and technology.
By 1984, the Zebra (sodium-nickel chloride) battery had been built and demonstrated in an electric vehicle, and commercialisation efforts began in earnest. But they were way ahead of their time and in 1986 the CSIR sold its stake in the Zebra battery and 20 years later Anglo American and Daimler-Benz (which had joined the commercialisation efforts) withdrew from further development of the battery. Meanwhile, Thackeray h
MedCity News
Biotech IPO wave rolls on as Werewolf, Vaccitech raise $230M for clinical trials
Vaccitech and Werewolf Therapeutics joined the public markets, raising a combined $230 million. The vaccine developer and the cancer immunotherapy biotech will apply the IPO proceeds toward clinical development of their respective pipelines.
Shares0
Two more biotech companies are joining the public markets. Werewolf Therapeutics and Vaccitech priced their respective IPOs late Thursday, raising a combined $230 million for multiple clinical trials.
Werewolf was able to boost the size of its deal, selling 7.5 million shares, up from the 6.25 million shares that it had initially planned to offer. Those shares were priced at $16 each, right at the midpoint of the biotech’s projected price range, and the company was able to gross $120 million. Werewolf’s shares will trade on the Nasdaq under the stock symbol “HOWL.”
New expert council formed to maximise UK investment offer
Investment Council will advise Government’s ambitious inward investment strategy
From:
27 April 2021
Today (April 27) Minister for Investment Gerry Grimstone has announced the creation of an Investment Council to act as an advisory body to the UK Government on foreign investment, to improve and enhance the UK’s business environment for foreign investors.
Made up of private sector senior leaders from around the globe in a variety of industries – from technology and energy to infrastructure and financial services – the Council will cement the investor lens in the Government’s inward investment strategy.
(Reuters) - Biotech startup Vaccitech, which co-invented the COVID-19 vaccine developed by AstraZeneca Plc and Oxford University, said on Monday it was aiming for a valuation of up to $613 million in its U.S. initial public offering.
The company, which has development programs for conditions including hepatitis B, prostate cancer and non-small cell lung cancer, has raised $216 million to date from Gilead Sciences , Sequoia Capital China and Oxford Sciences Innovation among others